Dissection of a Quantitative Trait Locus for PR Interval Duration Identifies as a Novel Modulator of Cardiac Conduction

English version České info

Atrio-ventricular conduction disease is a common feature in Mendelian rhythm disorders associated with sudden cardiac death and is characterized by prolongation of the PR interval on the surface electrocardiogram (ECG). Prolongation of the PR interval is also a strong predictor of atrial fibrillation, the most prevalent sustained cardiac arrhythmia. Despite the significant genetic component in PR duration variability, the genes regulating PR interval duration remain largely elusive. We here aimed to dissect the quantitative trait locus (QTL) for PR interval duration that we previously mapped in murine F2 progeny of a sensitized 129P2 and FVBN/J cross. To determine the underlying gene responsible for this QTL, genome-wide transcriptional profiling was carried out on myocardial tissue from 109 F2 mice. Expression QTLs (eQTLs) were mapped and the PR interval QTL was inspected for the co-incidence of eQTLs. We further determined the correlation of each of these transcripts to the PR interval. Tnni3k was the only eQTL, mapping to the PR-QTL, with an established abundant cardiac-specific expression pattern and a significant correlation to PR interval duration. Genotype inspection in various inbred mouse strains revealed the presence of at least three independent haplotypes at the Tnni3k locus. Measurement of PR interval duration and Tnni3k mRNA expression levels in six inbred lines identified a positive correlation between the level of Tnni3k mRNA and PR interval duration. Furthermore, in DBA/2J mice overexpressing hTNNI3K, and in DBA.AKR.hrtfm2 congenic mice, which harbor the AKR/J “high-Tnni3k expression” haplotype in the DBA/2J genetic background, PR interval duration was prolonged as compared to DBA/2J wild-type mice (“low-Tnni3k expression” haplotype). Our data provide the first evidence for a role of Tnni3k in controlling the electrocardiographic PR interval indicating a function of Tnni3k in atrio-ventricular conduction.

Vyšlo v časopise: Dissection of a Quantitative Trait Locus for PR Interval Duration Identifies as a Novel Modulator of Cardiac Conduction. PLoS Genet 8(12): e32767. doi:10.1371/journal.pgen.1003113
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003113

Souhrn

Zdroje

1. BensonD (2004) Genetics of atrioventricular conduction disease in humans. Anat Rec A Discov Mol Cell Evol Biol 280: 934–939.

2. ChengS, KeyesMJ, LarsonMG, McGabeEL, Newton-ChehC, et al. (2009) Long-term Outcomes in Individuals With Prolonged PR Interval or First Degree Atrioventricular Block. JAMA 301: 2571–2577.

3. SmithJG, MagnaniJW, PalmerC, MengYA, SolimanEZ, et al. (2011) Genome-wide association studies of the PR interval in African Americans. PLoS Genet 7: e1001304 doi:10.1371/journal.pgen.1001304.

4. HeeringaJ, ConwaymD, van der KuipD, HofmanA, KorsJ, et al. (2006) Prevalence incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27: 949–953.

5. HavlikR, GarrisonR, FabsitzR, FeinleibM (1980) Variability of heart rate, P-R, QRS and Q-T durations in twins. J Electrocardiol 13: 45–48.

6. SmithJG, LoweJK, KovvaliS, MallerJB, SalitJ, et al. (2009) Genome-wide association study of electrocardiographic conduction measures in an isolated founder population: Kosrae. Heart Rhythm 6: 634–641.

7. Newton-ChehC, GuoCY, WangTJ, O'DonnellCJ, LevyD, et al. (2007) Genome-wide association study of electrocardiographic and heart rate variability traits: the Framingham Heart Study. BMC Med Genet 8 Suppl 1: S7.

8. SciclunaBP, TanckMW, RemmeCA, BeekmanL, CoronelR, et al. (2011) Quantitative trait loci for electrocardiographic parameters and arrhythmia in the mouse. J Mol Cell Cardiol 50: 380–389.

9. RemmeCA, SciclunaBP, VerkerkAO, AminAS, van BrunschotS, et al. (2009) Genetically determined differences in sodium current characteristics modulate conduction disease severity in mice with cardiac sodium channelopathy. Circ Res 104: 1283–1292.

10. SciclunaBP, WildeAA, BezzinaCR (2008) The primary arrhythmia syndromes: same mutation, different manifestations. Are we starting to understand why? J Cardiovasc Electrophysiol 19: 445–452.

11. HubnerN, WallaceCA, ZimdahlH, PetrettoE, SchulzH, et al. (2005) Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet 37: 243–253.

12. BogueMA, GrubbSC (2004) The Mouse Phenome Project. Genetica 122: 71–74.

13. http://www.ncbi.nlm.nih.gov/sites/GDSbrowser?acc=GDS3142.

14. ThorrezL, Van DeunK, TrancheventLC, Van LommelL, EngelenK, et al. (2008) Using ribosomal protein genes as reference: a tale of caution. PLoS ONE 3: e1854 doi:10.1371/journal.pone.0001854.

15. http://msub.csbio.unc.edu/.

16. WheelerFC, TangH, MarksOA, HadnottTN, ChuPL, et al. (2009) Tnni3k modifies disease progression in murine models of cardiomyopathy. PLoS Genet 5: e1000647 doi:10.1371/journal.pgen.1000647.

17. http://phenome.jax.org/.

18. BerthonnecheC, PeterB, SchupferF, HayozP, KutalikZ, et al. (2009) Cardiovascular response to beta-adrenergic blockade or activation in 23 inbred mouse strains. PLoS ONE 4: e6610 doi:10.1371/journal.pone.0006610.

19. YangH, WangJR, DidionJP, BuusRJ, BellTA, et al. (2011) Subspecific origin and haplotype diversity in the laboratory mouse. Nat Genet 43: 648–655.

20. SchadtEE, LambJ, YangX, ZhuJ, EdwardsS, et al. (2005) An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 37: 710–717.

21. PetrettoE, SarwarR, GrieveI, LuH, KumaranMK, et al. (2008) Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet 40: 546–552.

22. BarrettT, TroupD, WilhiteS, LedouxP, EvangelistaC, et al. (2011) NCBI GEO: archive for functional genomics data sets—10 years on. Nucleic Acids Res 39: D1005–1010.

23. ZhaoY, MengX, WeiY, ZhaoX, LiuD, et al. (2003) Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I. J Mol Med 81: 297–304.

24. RemmeCA, VerkerkAO, NuyensD, van GinnekenAC, van BrunschotS, et al. (2006) Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation 114: 2584–2594.